Surface Oncology, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Surface Oncology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2022.
  • Surface Oncology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$28.2M, a 11.8% decline year-over-year.
  • Surface Oncology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$92.5M, a 46.9% decline year-over-year.
  • Surface Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$63.6M, a 19% increase from 2021.
  • Surface Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$78.5M, a 232% decline from 2020.
  • Surface Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was $59.3M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$63.6M +$14.9M +19% Jan 1, 2022 Dec 31, 2022 8-K 2023-07-03
2021 -$78.5M -$138M -232% Jan 1, 2021 Dec 31, 2021 8-K 2023-07-03
2020 $59.3M +$114M Jan 1, 2020 Dec 31, 2020 8-K 2023-07-03
2019 -$54.8M -$48.2M -731% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
2018 -$6.6M +$38.8M +85.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
2017 -$45.4M -$27.9M -160% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
2016 -$17.5M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.